Search

A novel treatment for prostate cancer involves a light-sensitive drug that destroys small tumors and the blood vessels that feed them.

The new Evelyn H. Lauder Breast Center of Memorial Sloan Kettering Cancer Center and the Memorial Sloan Kettering Cancer Center Imaging Center have opened, offering patients the most advanced outpatient services for cancer diagnosis and breast cancer treatment and detection.

Craig B. Thompson, MD, President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to City & State’s 2022 Health Care Power 100 list.

A new study from Kenneth Offit, MD, Chief of the Clinical Genetics Service and Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center (MSK), finds that more than half of inherited cancer gene mutations in people with advanced cancer are not detected using traditional methods based on family history.

In her new role, Dr. Hsu will work to diversify matriculating classes and train students to become skilled leaders as both clinicians and biomedical researchers.

When this feathered patient found her way into a New York laboratory in 1909, she changed the course of cancer science.

Learn how developmental biologists at MSK solved a decades-old cellular mystery. Their findings will have an immediate and lasting impact on the understanding and treatment of ciliopathies, which cause a host of medical problems and affect 1 in 2,000 people worldwide.

Learn about a new multiple myeloma drug that can stop the disease after other treatments have failed.